To confirm the role of Skp2 in prostate cancer progression, we performed a retrospective analysis of Skp2 expression in patients with benign hyperplasia and prostate carcinoma (Supplementary Tables S4 and S5). This evidence concerns the gene SKP2 and prostate carcinoma.